Evolus, Inc. (EOLS) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 36 days, typically, give or take 12 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Wed, Nov 4, 2026after close 35 8-K
Q2 FY2026Wed, Aug 5, 2026after close 36 8-K
Q1 FY2026Mon, May 4, 2026after close 34 8-K
Q4 FY2025Tue, Mar 3, 2026after close 62 8-K
Q3 FY2025Wed, Nov 5, 2025after close 36 8-K
Q2 FY2025Tue, Aug 5, 2025after close 36 8-K
Q1 FY2025Wed, May 7, 2025after close 37 8-K
Q4 FY2024Tue, Mar 4, 2025after close 63 8-K

What they guided beta

Q3 FY2026 "Document Evolus Reports Third Quarter 2026 Financial Results with 13% Year-Over-Year Revenue Growth; Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year 2026 Financial Outlook" exhibit
Q3 FY2026 "Reaffirms Full-Year 2026 Net Revenue Guidance of $330 Million to $337 Million, Reaffirms Adjusted Gross Profit Margin Guidance of 67.0% to 67.5%; Updates Non-GAAP Operating Expense Guidance to $210 Million to $213 Million, While Reaffirming Low- to Mid-Single Digit Adjusted EBITDA Margin Outlook" exhibit
Read from the sentence: revenue $330 million to $337 million, FY2026
Q3 FY2026 "Reaffirms 2028 Long-Term Financial Outlook Reflecting Total Net Revenue Between $450 Million and $500 Million, Representing a Three-Year CAGR of 15% to 19%, and Adjusted EBITDA Margins of 13% to 15% for 2028 NEWPORT BEACH, Calif., November 4, 2026 – Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands , today announced its financial results for the third quarter ended September 30, 2026." exhibit
Q3 FY2026 "These results reinforce our confidence in our full-year 2026 financial outlook, while the anticipated FDA approval of Evolysse ® Sculpt by year-end represents an additional opportunity to expand our portfolio and support progress toward our 2028 revenue and Adjusted EBITDA margin objectives.”" exhibit
Q3 FY2026 "Outlook – Full-Year 2026 Guidance and Expectations:" exhibit
Q2 FY2026 "Document Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook" exhibit
Q2 FY2026 "Raises Full-Year 2026 Net Revenue Guidance to Between $330 Million and $337 Million, Raises Adjusted Gross Profit Margin Guidance to Between 67.0% and 67.5%, Narrows Non-GAAP Operating Expense Guidance to Between $212 Million and $216 Million, While Reaffirming Low- to Mid-Single Digit Adjusted EBITDA Margin Outlook" exhibit
Read from the sentence: revenue $330 million to $337 million, FY2026
Q2 FY2026 "Expansion of the Company’s Global Injectable Portfolio Through the Addition of Profhilo ® , the Third Vertical in the U.S. Injectable Portfolio, With Estimated Peak Annual Revenue Exceeding $100 Million and Anticipated U.S. Commercialization in 2030, and the Expansion of the Estyme ® Franchise into Canada, Australia, and New Zealand, With Expected Commercialization in 2028" exhibit
Q2 FY2026 "Reaffirms 2028 Long-Term Financial Outlook Reflecting Total Net Revenue Between $450 million and $500 million, Representing a Three-Year CAGR of 15% to 19%, and Adjusted EBITDA Margins of 13% to 15% for 2028 NEWPORT BEACH, Calif., August 5, 2026 – Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the second quarter ended June 30, 2026." exhibit
Q2 FY2026 "Based on our first-half results, we are raising our full-year 2026 financial outlook while continuing to invest in strategic opportunities that strengthen our long-term growth profile." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/EOLS
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/EOLS

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

EOLS earnings date badge

HTML

<a href="https://veritasdata.dev/company/EOLS/"><img src="https://veritasdata.dev/embed/EOLS.svg" alt="EOLS earnings date" width="240" height="56"></a>

Markdown

[![EOLS earnings date](https://veritasdata.dev/embed/EOLS.svg)](https://veritasdata.dev/company/EOLS/)

Script

<script async src="https://veritasdata.dev/embed/EOLS.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/EOLS"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.